II Imunon, Inc. Stock: price and management transactions · United States · SEC (Form 4)Follow the Imunon, Inc. stock price and the full insider trade history of the company, a publicly traded company based in United States. Shares are listed on the US market, under the supervision of SEC (Form 4). Market capitalisation: €9.3m. The latest transaction was reported on 17 August 2026 (Attribution). Among the most active insiders: Eylward Susan. Every trade is free.
Analyst consensus: bullish or bearish? Analysts rate Imunon, Inc. Strong Buy (bullish), based on 5 analysts. Average price target: US$17.00.
Buys €72,287 €11,756 Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ Sigma AI Analysis Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 17 August 2026
All Executives41 Thresholds0 Prospectus0 Other0
Declarations 41 total
◆ General Counsel and Corp Sec · Executives · 14 Aug 2026
2,449 shares @ US$1.65 0.044% mcap 14.7% of flow Common Stock SEC:0001437749-26-028184:0
▼ General Counsel and Corp Sec · Executives · 17 Aug 2026
2,449 shares @ US$1.6303 0.043% mcap 14.5% of flow Common Stock SEC:0001437749-26-028184:1
◆ Chief Medical Officer · Executives · 14 Aug 2026
3,516 shares @ US$1.65 0.063% mcap 29.3% of flow Common Stock SEC:0001437749-26-028186:0
◆ Executive Chairman of Board · Executives · 14 Aug 2026
7,147 shares @ US$1.65 0.13% mcap 17.9% of flow Common Stock SEC:0001437749-26-028185:0
◆ President and CEO · Executives · 14 Aug 2026
6,615 shares @ US$1.65 0.12% mcap 18.6% of flow Common Stock SEC:0001437749-26-028187:0
▼ General Counsel and Corp Sec · Executives · 3 Aug 2026
2,541 shares @ US$1.5651 0.060% mcap 20.5% of flow Common Stock SEC:0001437749-26-025661:1
◆ Director · Executives · 31 Jul 2026
6,934 shares @ US$1.59 0.17% mcap 16.8% of flow Common Stock SEC:0001437749-26-025667:0
◆ Director · Executives · 31 Jul 2026
6,180 shares @ US$1.59 0.15% mcap 14.1% of flow Common Stock SEC:0001437749-26-025663:0
◆ President and CEO · Executives · 31 Jul 2026
5,010 shares @ US$1.59 0.12% mcap 16.7% of flow Common Stock SEC:0001437749-26-025655:0
◆ General Counsel and Corp Sec · Executives · 31 Jul 2026
2,541 shares @ US$1.59 0.061% mcap 20.9% of flow Common Stock SEC:0001437749-26-025661:0
◆ Chief Medical Officer · Executives · 31 Jul 2026
3,649 shares @ US$1.59 0.087% mcap 41.5% of flow Common Stock SEC:0001437749-26-025658:0
◆ Executive Chairman of Board · Executives · 31 Jul 2026
6,358 shares @ US$1.59 0.15% mcap 18.7% of flow Common Stock SEC:0001437749-26-025660:0
◆ Director · Executives · 31 Jul 2026
6,934 shares @ US$1.59 0.17% mcap 34.9% of flow Common Stock SEC:0001437749-26-025671:0
◆ Director · Executives · 31 Jul 2026
6,934 shares @ US$1.59 0.17% mcap 17.7% of flow Common Stock SEC:0001437749-26-025665:0
◆ Chief Medical Officer · Executives · 17 Jul 2026
3,082 shares @ US$1.83 0.073% mcap 69.3% of flow Common Stock SEC:0001437749-26-023947:0
◆ President and CEO · Executives · 17 Jul 2026
4,907 shares @ US$1.83 0.12% mcap 22.8% of flow Common Stock SEC:0001437749-26-023946:0
▼ General Counsel and Corp Sec · Executives · 20 Jul 2026
2,150 shares @ US$1.7816 0.050% mcap 34.0% of flow Common Stock SEC:0001437749-26-023948:1
◆ Executive Chairman of Board · Executives · 17 Jul 2026
4,603 shares @ US$1.83 0.11% mcap 19.3% of flow Common Stock SEC:0001437749-26-023949:0
◆ General Counsel and Corp Sec · Executives · 17 Jul 2026
2,150 shares @ US$1.83 0.051% mcap 34.9% of flow Common Stock SEC:0001437749-26-023948:0
◆ General Counsel and Corp Sec · Executives · 2 Jul 2026
920 shares @ US$1.91 0.021% mcap 50.4% of flow Common Stock SEC:0001437749-26-022944:0
▼ General Counsel and Corp Sec · Executives · 6 Jul 2026
920 shares @ US$1.88 0.021% mcap 49.6% of flow Common Stock SEC:0001437749-26-022944:1
◆ Chief Medical Officer · Executives · 2 Jul 2026
1,308 shares @ US$1.91 0.030% mcap 100.0% of flow Common Stock SEC:0001437749-26-022943:0
◆ President and CEO · Executives · 2 Jul 2026
2,534 shares @ US$1.91 0.058% mcap 15.9% of flow Common Stock SEC:0001437749-26-022941:0
◆ Executive Chairman of Board · Executives · 2 Jul 2026
4,410 shares @ US$1.91 0.10% mcap 23.9% of flow Common Stock SEC:0001437749-26-022948:0
◆ President and CEO · Executives · 25 Jun 2026
67,150 shares Common Stock SEC:0001437749-26-022001:0
25 of 41 declarations
Load more (16 remaining) Acerca de Imunon, Inc. Imunon, Inc. es una empresa centrada en el desarrollo de tratamientos de inmunoterapia. Su objetivo es proporcionar soluciones innovadoras para enfermedades graves.